11 research outputs found
GUIDING THE IMPLEMENTATION OF QUALITY IMPROVEMENT PROJECTS: A TOC APPROACH
No full textMany research has shown that approximately 70% of every medium to large scale industries have some type of quality improvement (QI) program. Depending on various independent studies, researchers have concluded that only onefifth of all QI projects show attractive output. The reason for this disappointing result is most of the QI programs are not result oriented. The main aim of this paper is to elaborate the value of using the Theory of Constraints (TOC), so that a result-oriented QI program can be achieved with a better bottom-line impact, which will be better than the traditional cost based selection process
Solvent effect on the charge transfer absorption bands of chloranil-aromatic hydrocarbon complexes
No full text510-511The charge transfer (CT) absorption bands of chloranil complexes with aromatic hydrocarbons such as benzene, toluene, xylene (o-, m- and p-), mesitylene and pyrene have been measured in different solvents and different values have been obtained in each set of the complexes. The CT energies of each complex in different solvents are plotted against the refractive index functions of the solvents and the extrapolated values obtained at unit refractive index are considered to be the corresponding values of the complexes in the gas phase
INVENTORY CONTROL USING ABC AND HML ANALYSIS – A CASE STUDY ON A MANUFACTURING INDUSTRY
No full textInherent uncertainties in demands and supply make it difficult for supply chains to achieve optimum inventory replenishment, resulting in loss of sales or keeping excessive inventories. An unkempt inventory can take up to one-third of an organization’s annual investment. Therefore, in order to compete with invariably erratic demands, it is not only challenging to develop an intelligent system to maintain and control an optimum level of inventory but has also become mandatory. Here we have tried to study the inventory control system of an EMU coach manufacturing industry using ABC and HML analysis method
Herbal Approaches for the Treatment of Hypertension: A Literature Review
No full textBackground- High blood pressure is a very common disease in most countries. This can also cause the worsening of other cardiovascular disorders. The total number of people who are suffering from hypertension has elevated in the past thirty years. It impacts the quality of life and it can be caused due to many factors like the lifestyle of the patient (inactivity), stress, obesity, stress, alcohol consumption, unhealthy food habits, age, and other underlying diseases. It is estimated that the cases of hypertension will rise up to 23.25 % by the year 2025 in India. Its occurrence in urban areas is more compared to the rural areas. In order to treat hypertension alternative medication can be used.
Method- To carry out this review we searched out the articles from various databases which includes PubMed, web of science and google scholar. All the papers that discussed about hypertension and its herbal remedies were screened.
Conclusion- Thus, the current review aimed to highlight various herbal drugs used for the treatment of hypertension. Many patients prefer herbal remedies over modern drugs. There are many herbal drugs available, which can be used for the successful treatment of high blood pressure like hibiscus, tulsi, garlic, Ashoka and etc
Behavioural activation therapy for depression in adults with non-communicable diseases
No full textBACKGROUND: Depression is common in people with non-communicable diseases (NCDs) such as cardiovascular disease, diabetes, cancer, and chronic respiratory conditions. The co-existence of depression and NCDs may affect health behaviours, compliance with treatment, physiological factors, and quality of life. This in turn is associated with worse outcomes for both conditions. Behavioural activation is not currently indicated for the treatment of depression in this population in the UK, but is increasingly being used to treat depression in adults. OBJECTIVES: To examine the effects of behavioural activation compared with any control group for the treatment of depression in adults with NCDs. To examine the effects of behavioural activation compared with each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment of depression in adults with NCDs. SEARCH METHODS: We searched CCMD-CTR, CENTRAL, Ovid MEDLINE, Embase, four other databases, and two trial registers on 4 October 2019 to identify randomised controlled trials (RCTs) of behavioural activation for depression in participants with NCDs, together with grey literature and reference checking. We applied no restrictions on date, language, or publication status to the searches. SELECTION CRITERIA: We included RCTs of behavioural activation for the treatment of depression in adults with one of four NCDs: cardiovascular disease, diabetes, cancer, and chronic respiratory conditions. Only participants with a formal diagnosis of both depression and an NCD were eligible. Studies were included if behavioural activation was the main component of the intervention. We included studies with any comparator that was not behavioural activation, and regardless of reported outcomes. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane, including independent screening of titles/abstracts and full-text manuscripts, data extraction, and risk of bias assessments in duplicate. Where necessary, we contacted study authors for more information. MAIN RESULTS: We included two studies, contributing data from 181 participants to the analyses. Both studies recruited participants from US hospital clinics; one included people who were recovering from a stroke and the other women with breast cancer. For both studies, the intervention consisted of eight weeks of face-to-face behavioural therapy, with one study comparing to poststroke treatment as usual and the other comparing to problem-solving therapy. Both studies were at risk of performance bias and potential conflict of interest arising from author involvement in the development of the intervention. For one study, risks of selection bias and reporting bias were unclear and the study was judged at high risk of attrition bias. Treatment efficacy (remission) was greater for behavioural activation than for comparators in the short term (risk ratio (RR) 1.53, 95% confidence interval (CI) 0.98 to 2.38; low-certainty evidence) and medium term (RR 1.76, 95% CI 1.01 to 3.08; moderate-certainty evidence), but these estimates lacked precision and effects were reduced in the long term (RR 1.42, 95% CI 0.91 to 2.23; moderate-certainty evidence). We found no evidence of a difference in treatment acceptability in the short term (RR 1.81, 95% CI 0.68 to 4.82) and medium term (RR 0.88, 95% CI 0.25 to 3.10) (low-certainty evidence). There was no evidence of a difference in depression symptoms between behavioural activation and comparators (short term: MD -1.15, 95% CI -2.71 to 0.41; low-certainty evidence). One study found no difference for quality of life (short term: MD 0.40, 95% CI -0.16 to 0.96; low-certainty evidence), functioning (short term: MD 2.70, 95% CI -6.99 to 12.39; low-certainty evidence), and anxiety symptoms (short term: MD -1.70, 95% CI -4.50 to 1.10; low-certainty evidence). Neither study reported data on adverse effects. AUTHORS' CONCLUSIONS: Evidence from this review was not sufficient to draw conclusions on the efficacy and acceptability of behavioural activation for the treatment of depression in adults with NCDs. A future review may wish to include, or focus on, studies of people with subthreshold depression or depression symptoms without a formal diagnosis, as this may inform whether behavioural activation could be used to treat mild or undiagnosed (or both) depressive symptoms in people with NCDs. Evidence from low-resource settings including low- and middle-income countries, for which behavioural activation may offer a feasible alternative to other treatments for depression, would be of interest
